{
    "2018-10-11": [
        [
            {
                "time": "2018-10-10",
                "original_text": "Abbott Laboratories Expected to Report Q3 Sales of $7.6 Billion",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "Q3 Sales",
                        "Expected",
                        "$7.6 Billion"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-10",
                "original_text": "JNJâ€™s Consumer Business Expected to Be Driven by Innovation",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Consumer Business",
                        "Innovation",
                        "Expected"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2018",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "Ex-Dividend Date",
                        "Scheduled",
                        "October 12, 2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-10",
                "original_text": "Analysts Raise Target Prices on ABT ahead of Q3 Earnings",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Raise",
                        "Target Prices",
                        "ABT",
                        "Q3 Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}